ÂÜÀòÂÒÂ×

Kelly M. McVearry serves as Chairman and Managing Partner of the Hypatia Group, leading initiatives to enhance human healthspan, advance health equity, and foster economic prosperity. McVearry holds multiple leadership roles within HYPATIA, including Managing Director of HYPATIA VETS and CEO of the Hypatia Project, focusing on providing advanced IT services and innovation partnerships for public sector challenges. In addition, McVearry contributes to the National Center for Advancing Translational Sciences and is a co-chair of the FDA's Lupus Accelerating Breakthroughs Consortium. Other notable positions include co-founder and CEO of Bento Biology Platforms and roles in Life Science Angels, as well as extensive experience in corporate strategy and health information systems at Northrop Grumman. McVearry's educational background includes a Ph.D. in Neuroscience from Georgetown University, multiple master's degrees, and diverse roles in academia and industry dedicated to improving health and educational outcomes.